Charity Accounts Intelreading the accounts so you don’t have to

STRUCTURAL GENOMICS CONSORTIUM

Registered charity 1097737 · accounts filings on the Charity Commission register

Latest income
£4.7m
Latest spending
£5.1m
Registered
2003
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that the charity reported a net expenditure of £415,000 for the year, with unrestricted reserves declining to £1,909,000. The trustees confirm the entity is a going concern, citing approved funding applications expected to be completed by November 2025. The charity operates on a five-year funding cycle and aims to break even at the end of the current period.

What the accounts disclose

Reserves policy: sufficient funds in reserve to cover its grant commitments for this period to break-even at the end of the period (held: £1.9m)
“aims to keep sufficient funds in reserve to cover its grant commitments for this period to break-even at the end of the period as achieved in previous phases.” — page 9
Per its FY2025 accounts as filed with the Charity Commission.
Payments to trustees: Chair remuneration £10,000
“Remuneration was payable to the Chair of the Board during the year, in relation to her responsibilities as Chair, amounting to £10,000 (2024: £10,000).” — page 24
Per its FY2025 accounts as filed with the Charity Commission.

Accounts audited by CT Audit Limited.

Leadership, per the charity’s website

Listed on the charity’s own website when we last crawled it; roles may have changed. Pay-band disclosures above are anonymous statutory disclosures and are not attributed to any named individual.

Funders the charity credits

Named as funders/supporters on the charity’s own website (the charity’s claim, distinct from accounts-verified grants).

Structured financials (annual return, FY ending 30/06/2025)

Total income
£4.7m
Total spending
£5.1m
Reserves (reported)
£3.5m
Employees
0

Reported reserves equal ~8.1 months of spending — above the median for charities its size (median 4.8 months; benchmarks).

Trustees

Trustee list from the Charity Commission register (current, not historical).

Operates in: Canada · Germany · Japan · Sweden · Switzerland · Throughout England And Wales · United States

Income and spending

Financial year endIncomeSpending
30/06/2025£4.7m£5.1m
30/06/2024£14k£2.4m
30/06/2023£0£4.0m
30/06/2022£4.8m£3.6m
30/06/2021£10.3m£8.5m

Common questions

Is STRUCTURAL GENOMICS CONSORTIUM financially healthy?

The accounts state that the charity reported a net expenditure of £415,000 for the year, with unrestricted reserves declining to £1,909,000. The trustees confirm the entity is a going concern, citing approved funding applications expected to be completed by November 2025. The charity operates on a five-year funding cycle and aims to break even at the end of the current period. Its FY2025 accounts were audited by CT Audit Limited.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

FunderSimilar charities fundedAmount to them
THE LORD FARINGDON CHARITABLE TRUST2£5k
THE MAURICE WOHL CHARITABLE FOUNDATION1£400k
THE CHARLES WOLFSON CHARITABLE TRUST1£150k
Blood Cancer UK Research1£87k
PROJECT GIVING BACK1£84k
THE REGATTA FOUNDATION1£50k
Arthritis UK1£50k
JUVENILE DIABETES RESEARCH FOUNDATION LIMITED1£38k

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with THE LORNA AND YUTI CHERNAJOVSKY BIOMEDICAL RESEARCH FOUNDATION.